Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Noninvasive Fetal Sex Determination Test Between 6 and 16 Weeks of Gestation

NCT00970047 is registered in ClinicalTrials.gov with Sequenom, Inc. as lead sponsor.

NCT NCT00970047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00970047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Noninvasive Fetal Sex Determination Test Between 6 and 16 Weeks of Gestation
Lead sponsor
Sequenom, Inc.
Phase
Observational
Overall status
Completed
Start date
June 30, 2008
Completion date
July 31, 2010
Enrollment
500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

fetal sex determination